At the final end of the analysis, researchers were forced to conclude that in the entire year after treatment, there were as many attempted suicides in the group that acquired received additional intervention as in the control group that received standard treatment. Hence there is no difference found in either hospital registers or in the data gathered from self-reporting by individuals in the analysis: Unfortunately, the conclusion should be that neither standard treatment nor additional assertive outreach is sufficient. My suggestion is that we try to get hold of teenagers at risk before they attempt suicide the first time. We are looking with interest at some American Teen-Screen programmes, which look at young people’s mental wellness generally, to observe if any danger can be identified by us signals to which we could respond earlier, explains Britt Morthorst.Â..Kaiser Health Information, an editorially independent news service, is a scheduled system of the Kaiser Family Foundation, a nonpartisan health care policy research company unaffiliated with Kaiser Permanente.
Cardium to improve $5.0 million in registered direct offering Cardium Therapeutics today announced that it has entered into definitive agreements with 3 institutional and accredited traders to sell an aggregate of 17,857,143 shares of its common share in a registered direct supplying for gross proceeds of approximately $5.0 million, before deducting placement agent’s fees and estimated offering expenses. The traders have agreed to purchase the shares of common share for a price of $0.28 per share with no warrant coverage.